Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244)

被引:173
作者
Eissmann, P
Beauchamp, L
Wooters, J
Tilton, JC
Long, EO
Watzl, C
机构
[1] Univ Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany
[2] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA
[3] Wyeth Res, Cambridge, England
关键词
D O I
10.1182/blood-2004-09-3796
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Triggering of 2B4 (CD244) can induce natural killer (NK)-cell activation, costimulation, or even inhibition of NK-cell activity. Here, we investigate the molecular basis for the different signals generated by 2B4. We show that the first immunoreceptor tyrosine-based switch motif (ITSM) within the cytoplasmic tail of 2B4 is sufficient for 2B4-mediated NK-cell activation, whereas the third ITSM can negatively influence 2B4 signaling. We further identify signaling molecules that associate with 2B4. Signaling lymphocyte activation molecule-associated protein (SAP) can bind to all 4 ITSMs of 2B4 in a phosphorylation-dependent manner. The phosphorylated third ITSM can additionally recruit the phosphatases SHP-1, SHP-2, SHIP, and the inhibitory kinase Csk. SAP acts as an inhibitor of interactions between 2B4 and these negative regulatory molecules, explaining how 2B4 inhibits NK-cell activation in the absence of functional SAP, as occurs in cells from patients with X-linked lymphoproliferative syndrome (XLP). Recently, another function for SAP was proposed: SAP can recruit the kinase Fyn to the SLAM (CD150) immune receptor. We now show that Fyn can also associate with phosphorylated 2B4. Finally, we demonstrate that Fyn and Csk can both phosphorylate 2B4, suggesting a possible mechanism of 2B4 phosphorylation. (c) 2005 by The American Society of Hematology.
引用
收藏
页码:4722 / 4729
页数:8
相关论文
共 56 条
[1]   Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase [J].
Aoukaty, A ;
Tan, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) :13331-13337
[2]   Cutting edge: Defective NK cell activation in X-linked lymphoproliferative disease [J].
Benoit, L ;
Wang, XX ;
Pabst, HF ;
Dutz, J ;
Tan, R .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3549-3553
[3]   Human natural killer cell receptors and co-receptors [J].
Biassoni, R ;
Cantoni, C ;
Pende, D ;
Sivori, S ;
Parolini, S ;
Vitale, M ;
Bottino, C ;
Moretta, A .
IMMUNOLOGICAL REVIEWS, 2001, 181 :203-214
[4]   ITAMs versus ITIMs: striking a balance during cell regulation [J].
Billadeau, DD ;
Leibson, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (02) :161-168
[5]   2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes [J].
Boles, KS ;
Stepp, SE ;
Bennett, M ;
Kumar, V ;
Mathew, PA .
IMMUNOLOGICAL REVIEWS, 2001, 181 :234-249
[6]  
Bottino C, 2000, EUR J IMMUNOL, V30, P3718
[7]   GNTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr-virus-infected B cells in X-linked lymphoproliferative disease [J].
Bottino, C ;
Falco, M ;
Parolini, S ;
Marcenaro, E ;
Augugliaro, R ;
Sivori, S ;
Landi, E ;
Biassoni, R ;
Notarangelo, LD ;
Moretta, L ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) :235-246
[8]   2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 [J].
Brown, MH ;
Boles, K ;
van der Merwe, PA ;
Kumar, V ;
Mathew, PA ;
Barclay, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2083-2090
[9]   NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer [J].
Cerwenka, A ;
Lanier, LL .
TISSUE ANTIGENS, 2003, 61 (05) :335-343
[10]   SAP couples Fyn to SLAM immune receptors [J].
Chan, B ;
Lanyi, A ;
Song, HK ;
Griesbach, J ;
Simarro-Grande, M ;
Poy, F ;
Howie, D ;
Sumegi, J ;
Terhorst, C ;
Eck, MJ .
NATURE CELL BIOLOGY, 2003, 5 (02) :155-160